SpringRock Ventures focuses on investing in the convergence of healthcare and information technology, targeting early to late-stage, high-growth potential companies in areas such as digital health, medical devices, SaaS, and oral health. Their strategy involves partnering with entrepreneurial teams to provide strategic guidance and support for disruptive solutions improving general health.
Portfolio
7
Fund Size
—
Top Stage
Series A
Last 12 Mo
0
Stage Distribution
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| DexCare | Series C | $75M | Jun 2023 |
| DexCare, Inc. | Series C | $75M | Jun 2023 |
| Vouched | Seed | $6.3M | Feb 2023 |
| DexCare | Series B | $50M | Jan 2022 |
| DexCare | Series A | $20M | Mar 2021 |
| Carrum Health | Series A | $40M | Jan 2021 |
| GRIN | Seed | $10M | — |
Top Co-Investors
Frist Cressey Ventures4 shared
Kaiser Permanente Ventures4 shared
Transformation Capital3 shared
Providence Ventures2 shared
Iconiq Capital2 shared
Tiger Global Management1 shared
Cross Creek1 shared
Wildcat Capital Management1 shared
TriVentures1 shared
Mass General Brigham Ventures1 shared
Last updated: 3 March 2026